Alopecia Grugs Market To Grow To US$ 10,992.9 Million By 2026


Posted December 21, 2018 by krutika

The global alopecia drugs market was valued at US$ 6,901.8 Mn in 2016 and is projected to reach US$ 10,992.9 Mn in 2026 at a CAGR of 4.8% from 2017 to 2026.

 
Alopecia is a hair loss condition leading to partial or complete baldness in individuals. The severity of hair loss may vary from a small area to the entire body. Alopecia occurs due to fungal infections, serious health problems, and unhealthy conditions confined to scalp. Alopecia drugs are medications that helps to treat and prevent hair loss. There are three types of alopecia drugs – topical, oral, and injectable available in the market. In addition, prevalence of alopecia is more in males as compared to females, as their body generates high levels of dihydrotestosterone (DHT), that shrinks’ hair follicles resulting in loss of hair.

The global alopecia drugs market is projected to reach a value of over US$ 10,000 Mn in 2026 at a CAGR of 4.8% over the forecast period.

The major factor driving growth of the global market is the rising preference for approved drugs among individuals across the globe. Increasing number of chemotherapy therapy procedures across the globe leading to hair loss in the individuals is expected to support growth of the target market. In addition, there is a rising demand for hair loss treatment drugs with enhanced effectiveness and minimal side effects which is another factor driving growth of the target market. Various combination of drugs is being tried by the healthcare professionals to increase the effectiveness of treatment for alopecia. However, high cost of several topical medications and patent expiry of many drugs are expected to hamper growth of the global market.

Development of drugs that can eliminate side effects caused by conventional alopecia drugs can create high potential revenue opportunity for target players in the global alopecia drugs market.

The global alopecia drugs market report has been segmented on the basis of route of administration, gender, and region. On the basis of route of administration, the global market is segmented into oral, injectable and topical. The topical segment is expected to account for major share in terms of revenue in the global market and is projected to register a CAGR of over 5% over the forecast period. Male segment dominated the global alopecia drugs market in revenue terms, accounting for highest revenue share and registering a CAGR of over 4.5% during the forecast period 2017 & 2026.

On the basis of region, the global alopecia drugs market is segmented into The Americas, Europe, Asia Pacific, and Rest of the World. The market in North America is expected to account for highest market share in terms of revenue owing to government regulatory support for developing innovative drugs and increasing lifestyle changes such as physical inactivity and stress. The market in Europe holds the second highest share in terms of revenue owing to rising incidence of cancer patients and increasing penetration of advanced hair loss treatment therapies. The market in Asia Pacific is projected to register a significant growth of around 7%, which is relatively higher than that of markets in other regions.

Key players profiled in the global alopecia drugs market include Taisho Pharmaceutical Holdings Co. Ltd., The Himalaya Drug Company, Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., MERCK, Vitabiotics Ltd.

About Us:

MarketResearch.biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. MarketResearch.biz offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us:
Lawrence John
Prudour Pvt. Ltd.
420 Lexington Avenue, Suite 300
New York City, NY 10170,
United States
Email ID: [email protected]
Tel: +1-347-826-1876
Website: https://marketresearch.biz
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketResearch.Biz
Phone 3478261876
Business Address Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300
Country India
Categories Health , Marketing , Medical
Tags alopecia drugs , alopecia drugs market , market research
Last Updated December 21, 2018